{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:08:50Z","timestamp":1785247730071,"version":"3.55.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2011,11,29]],"date-time":"2011-11-29T00:00:00Z","timestamp":1322524800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0027860","type":"journal-article","created":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T04:35:17Z","timestamp":1322714117000},"page":"e27860","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["\u2018Multi-Epitope-Targeted\u2019 Immune-Specific Therapy for a Multiple Sclerosis-Like Disease via Engineered Multi-Epitope Protein Is Superior to Peptides"],"prefix":"10.1371","volume":"6","author":[{"given":"Nathali","family":"Kaushansky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kerlero de Rosbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Zilkha-Falb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Yosef-Hemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Ben-Nun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,11,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis.","volume":"23","author":"M Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"14599","DOI":"10.1073\/pnas.0404874101","article-title":"Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: from pipe dreams to (therapeutic) pipelines.","volume":"101","author":"R Hohlfeld","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/eji.1830110307","article-title":"The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.","volume":"11","author":"A Ben-Nun","year":"1981","journal-title":"Eur J Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4049\/jimmunol.130.3.1205","article-title":"Detection of autoimmune cells proliferating to myelin basic protein and selection of T cell lines that mediate experimental autoimmune encephalomyelitis (EAE) in mice.","volume":"130","author":"A Ben-Nun","year":"1983","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/317355a0","article-title":"T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination.","volume":"317","author":"S Zamvil","year":"1985","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2004.04.014","article-title":"Immunotherapeutic approaches in multiple sclerosis.","volume":"223","author":"L Adorini","year":"2004","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.7509084","article-title":"T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.","volume":"263","author":"JM Critchfield","year":"1994","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ana.410390108","article-title":"Intravenous antigen administration as a therapy for autoimmune demyelinating disease.","volume":"39","author":"MK Racke","year":"1996","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(97)00019-2","article-title":"Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide.","volume":"75","author":"B Devaux","year":"1997","journal-title":"J Neuroimmunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.4049\/jimmunol.162.6.3336","article-title":"Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation.","volume":"162","author":"PJ Ruiz","year":"1999","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1182\/blood.V97.4.886","article-title":"A gene therapy approach for treating T-cell-mediated autoimmune diseases.","volume":"97","author":"C Chen","year":"2001","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2447648","article-title":"Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.","volume":"239","author":"O Lider","year":"1988","journal-title":"Science"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1084\/jem.168.6.2153","article-title":"Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein.","volume":"168","author":"M Owhashi","year":"1988","journal-title":"J Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(88)90079-7","article-title":"Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy.","volume":"54","author":"JL Urban","year":"1988","journal-title":"Cell"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/341541a0","article-title":"Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis.","volume":"341","author":"AA Vandenbark","year":"1989","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1126\/science.2814489","article-title":"Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.","volume":"246","author":"MD Howell","year":"1989","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1073\/pnas.88.24.11465","article-title":"Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.","volume":"88","author":"SD Sharma","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.4049\/jimmunol.172.7.4556","article-title":"Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL\/J mice through cytokine switch.","volume":"172","author":"J Huan","year":"2004","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0092-8674(89)90287-0","article-title":"Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.","volume":"59","author":"DC Wraith","year":"1989","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4049\/jimmunol.161.1.504","article-title":"Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.","volume":"161","author":"EA Leadbetter","year":"1998","journal-title":"J Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00312812","article-title":"Failure of basic protein therapy for multiple sclerosis.","volume":"216","author":"RE Gonsette","year":"1977","journal-title":"J Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archneur.1973.00490250028003","article-title":"Myelin basic protein administration in multiple sclerosis.","volume":"29","author":"B Campbell","year":"1973","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1468-1331.2006.01533.x","article-title":"Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatment.","volume":"13","author":"KG Warren","year":"2006","journal-title":"Eur J Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/80525","article-title":"Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.","volume":"6","author":"L Kappos","year":"2000","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/80516","article-title":"Encephalitogenic potential of the myelin basic protein peptide (amino acids 83\u201399) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand.","volume":"6","author":"B Bielekova","year":"2000","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/358155a0","article-title":"Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.","volume":"358","author":"PV Lehmann","year":"1992","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/jaut.1998.0202","article-title":"T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.","volume":"11","author":"NK de Rosbo","year":"1998","journal-title":"J Autoimmun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-065X.1998.tb01211.x","article-title":"The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.","volume":"164","author":"VK Tuohy","year":"1998","journal-title":"Immunol Rev"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.182.1.75","article-title":"Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.","volume":"182","author":"BL McRae","year":"1995","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/eji.200324044","article-title":"Disease-related epitope spread in a humanized T cell receptor transgenic model of multiple sclerosis.","volume":"34","author":"S Ellmerich","year":"2004","journal-title":"Eur J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1172\/JCI119331","article-title":"Diversity and plasticity of self recognition during the development of multiple sclerosis.","volume":"99","author":"VK Tuohy","year":"1997","journal-title":"J Clin Invest"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0198-8859(97)00252-8","article-title":"HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis.","volume":"59","author":"M Yu","year":"1998","journal-title":"Hum Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1172\/JCI0215692","article-title":"Multiantigen\/multiepitope-directed immune-specific suppression of \u201ccomplex autoimmune encephalomyelitis\u201d by a novel protein product of a synthetic gene.","volume":"110","author":"MC Zhong","year":"2002","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.","volume":"13","author":"T Korn","year":"2007","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/eji.1830261030","article-title":"Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.","volume":"26","author":"N Mendel Kerlero de Rosbo","year":"1996","journal-title":"Eur J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/eji.1830250723","article-title":"A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.","volume":"25","author":"I Mendel","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0165-5728(00)00186-7","article-title":"T-cells specific for soluble recombinant oligodendrocyte-specific protein induce severe clinical experimental autoimmune encephalomyelitis in H-2(b) and H-2(s) mice.","volume":"105","author":"MC Zhong","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/eji.200535363","article-title":"Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.","volume":"36","author":"A Ben-Nun","year":"2006","journal-title":"Eur J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/eji.200636965","article-title":"OSP\/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207.","volume":"37","author":"N Kaushansky","year":"2007","journal-title":"Eur J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy.","volume":"2","author":"CL Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1034\/j.1600-0854.2000.010706.x","article-title":"Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.","volume":"1","author":"SS Pathak","year":"2000","journal-title":"Traffic"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ni1088","article-title":"The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.","volume":"5","author":"C Watts","year":"2004","journal-title":"Nat Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells.","volume":"21","author":"RM Steinman","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humimm.2003.11.002","article-title":"Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.","volume":"65","author":"Y Jin","year":"2004","journal-title":"Hum Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaut.2006.12.002","article-title":"Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities.","volume":"27","author":"CE Smith","year":"2006","journal-title":"J Autoimmun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.169.5.1681","article-title":"Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein.","volume":"169","author":"JP Clayton","year":"1989","journal-title":"J Exp Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1279812","article-title":"Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy.","volume":"258","author":"A Gaur","year":"1992","journal-title":"Science"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1172\/JCI118954","article-title":"Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.","volume":"98","author":"EA Elliott","year":"1996","journal-title":"J Clin Invest"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ana.22219","article-title":"Immune regulation of multiple sclerosis by transdermally applied myelin peptides.","volume":"68","author":"M Jurynczyk","year":"2010","journal-title":"Ann Neurol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2172-4-2","article-title":"Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus.","volume":"4","author":"R Pedotti","year":"2003","journal-title":"BMC Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1172\/JCI0215488","article-title":"Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self-peptides B:9\u201323 and B:13\u201323.","volume":"110","author":"E Liu","year":"2002","journal-title":"J Clin Invest"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/85266","article-title":"An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide.","volume":"2","author":"R Pedotti","year":"2001","journal-title":"Nat Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2165\/00023210-200216120-00004","article-title":"Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis.","volume":"16","author":"D Simpson","year":"2002","journal-title":"CNS Drugs"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1073\/pnas.0504131102","article-title":"Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.","volume":"102","author":"CE Smith","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-5728(99)00168-X","article-title":"The central nervous system-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS).","volume":"102","author":"JF Kaye","year":"2000","journal-title":"J Neuroimmunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/(SICI)1097-4547(19960815)45:4<471::AID-JNR17>3.0.CO;2-3","article-title":"Active and passive experimental autoimmune encephalomyelitis in strain 129\/J (H-2b) mice.","volume":"45","author":"RB Fritz","year":"1996","journal-title":"J Neurosci Res"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.4049\/jimmunol.153.10.4349","article-title":"Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB\/H mice.","volume":"153","author":"S Amor","year":"1994","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4049\/jimmunol.173.2.1426","article-title":"The myelin-associated oligodendrocytic basic protein region MOBP15-36 encompasses the immunodominant major encephalitogenic epitope(s) for SJL\/J mice and predicted epitope(s) for multiple sclerosis-associated HLA-DRB1*1501.","volume":"173","author":"NK de Rosbo","year":"2004","journal-title":"J Immunol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/BF00968703","article-title":"Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.","volume":"19","author":"VK Tuohy","year":"1994","journal-title":"Neurochem Res"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.4049\/jimmunol.177.10.7364","article-title":"Epitope specificity of autoreactive T and B cells associated with experimental autoimmune encephalomyelitis and optic neuritis induced by oligodendrocyte-specific protein in SJL\/J mice.","volume":"177","author":"N Kaushansky","year":"2006","journal-title":"J Immunol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0165-5728(88)90032-X","article-title":"Characterization of a major encephalitogenic T cell epitope in SJL\/J mice with synthetic oligopeptides of myelin basic protein.","volume":"19","author":"K Sakai","year":"1988","journal-title":"J Neuroimmunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"7501","DOI":"10.4049\/jimmunol.162.12.7501","article-title":"Oligodendrocyte-specific protein peptides induce experimental autoimmune encephalomyelitis in SJL\/J mice.","volume":"162","author":"DB Stevens","year":"1999","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0027860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T10:23:40Z","timestamp":1686479020000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0027860"}},"subtitle":[],"editor":[{"given":"Robyn","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,11,29]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2011,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0027860","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,29]]}}}